- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 12.08. | Syra Health Corp - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 12.08. | Syra Health Corp - 8-K, Current Report | 1 | SEC Filings | ||
| 12.08. | Syra Health Announces Second Quarter Financial Results, Advancing Toward Profitability on Margin Gains and Cost Reductions | 81 | PR Newswire | - Revenue of $1.9 Million consistent with the year-ago period- Revenue led by Population Health's growth up 197% compared to Q2 2024- Gross Margin... ► Artikel lesen | |
| 30.07. | Syra Health Corp - 8-K, Current Report | 2 | SEC Filings | ||
| 17.07. | Syra Health secures up to $2.1M contract to provide medical management nurses | 1 | Seeking Alpha | ||
| SYRA HEALTH Aktie jetzt für 0€ handeln | |||||
| 17.06. | Syra Health Corp - 8-K, Current Report | 1 | SEC Filings | ||
| 27.05. | Syra Health Wins $5.8 Mln Indiana Contract To Lead Child Mental Health Access Site | 1 | RTTNews | ||
| 20.05. | Syra Health Corp - 8-K, Current Report | 1 | SEC Filings | ||
| 20.05. | Syra Health embarks on search for new CEO | 1 | Investing.com | ||
| 20.05. | Syra Health beginnt Suche nach neuem CEO | 2 | Investing.com Deutsch | ||
| 20.05. | Syra Health Board Begins CEO Search to Drive Growth | 102 | PR Newswire | CARMEL, Ind., May 20, 2025 /PRNewswire/ -- Syra Health Corp. (OTCQB: SYRA) ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering... ► Artikel lesen | |
| 09.05. | Syra Health GAAP EPS of -$0.04, revenue of $1.86M | 1 | Seeking Alpha | ||
| 08.05. | Syra Health Corp - 8-K, Current Report | 1 | SEC Filings | ||
| 08.05. | Syra Health Corp - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 08.05. | Syra Health Announces First Quarter Revenue of $1.9 Million, Up 6% YoY | 114 | PR Newswire | Revenue increase led by Population Health's 261% YoY Expansion
Gross Margin Improves Substantially to 31.7%, up 14.6 Percentage Points YoY
Continued Efficiency Gains... ► Artikel lesen | |
| 08.04. | Syra Health Corp - 8-K, Current Report | 4 | SEC Filings | ||
| 01.04. | Syra Health to delist from Nasdaq Capital Market | 1 | Investing.com | ||
| 01.04. | Syra Health announces voluntary delisting from Nasdaq | 4 | Seeking Alpha | ||
| 01.04. | Syra Health kündigt Rückzug vom NASDAQ Capital Market an | 2 | Investing.com Deutsch | ||
| 01.04. | Syra Health Announces Voluntary Delisting from the Nasdaq Capital Market | 111 | PR Newswire | CARMEL, Ind., April 1, 2025 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA) ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering... ► Artikel lesen |
1 2 Weiter >>
23 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SERNOVA BIOTHERAPEUTICS | 0,112 | -0,88 % | Sernova Corp.: Sernova Biotherapeutics to Participate in the H.C. Wainwright 27th Annual Global Investor Conference | ||
| ATOSSA THERAPEUTICS | 0,680 | -0,44 % | Atossa Genetics stock rating reiterated by H.C. Wainwright on FDA meeting plans | ||
| PING AN HEALTHCARE | 2,516 | +1,49 % | Ping An Healthcare and Technology Company Limited: Ping An Good Doctor (1833.HK) Reports Solid Interim Results with Steady Revenue and Profit Growth | HONG KONG, Aug. 20, 2025 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited (the "Company"; Stock Code: 1833.HK) announced its interim results for the six months ended June... ► Artikel lesen | |
| MOUNTAIN VALLEY MD | 0,015 | 0,00 % | Mountain Valley MD Holdings Inc: Mountain Valley appoints Batchelor as director | ||
| CO-DIAGNOSTICS | 0,260 | -0,76 % | Co-Diagnostics, Inc. Reports Second Quarter 2025 Financial Results | SALT LAKE CITY, Aug. 14, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development... ► Artikel lesen | |
| VERU | 3,820 | 0,00 % | Veru Inc.: Veru Reports Fiscal 2025 Third Quarter Financial Results and Clinical Program Progress | --Company reported positive efficacy and safety data from Phase 2b QUALITY study showing enobosarm added to semaglutide led to preservation of muscle, greater fat loss, and fewer gastrointestinal... ► Artikel lesen | |
| CYTOSORBENTS | 0,853 | +5,96 % | CytoSorbents bei H.C. Wainwright: Strategisches Wachstum und regulatorische Herausforderungen | ||
| TEMPEST THERAPEUTICS | 6,010 | -100,00 % | Tempest Therapeutics: Tempest Reports Second Quarter 2025 Financial Results and Provides Business Update | Received clearance to proceed with pivotal trial of amezalpat combination therapy for first-line hepatocellular carcinoma (HCC) in ChinaGranted orphan drug designation from the European Medicines... ► Artikel lesen | |
| VOLITIONRX | 0,631 | 0,00 % | H.C. Wainwright bestätigt Kaufempfehlung für VolitionRX nach Partnerschaft mit Werfen | ||
| EKSO BIONICS | 4,070 | 0,00 % | Ekso Bionics Holdings, Inc.: Ekso Bionics Reports Second Quarter 2025 Financial Results | SAN RAFAEL, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) ("Ekso Bionics" or the "Company"), an industry leader in exoskeleton technology for medical and industrial... ► Artikel lesen | |
| IMUNON | 4,900 | +2,51 % | Imunon, Inc.: IMUNON Successfully Regains Compliance with Nasdaq Minimum Bid Price Listing Requirement | LAWRENCEVILLE, N.J., Aug. 28, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage company in Phase 3 development of its DNA-mediated immunotherapy, today announced that the Company... ► Artikel lesen | |
| BEYOND AIR | 2,260 | 0,00 % | Beyond Air, Inc. - 8-K, Current Report | ||
| AVINGER | 0,465 | -22,17 % | NSE - Avinger Inc - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
| NOVACYT | 0,449 | -5,87 % | Novacyt S.A. - Liquidity Agreement Monthly Update and TVR | ||
| AROVELLA THERAPEUTICS | 0,041 | 0,00 % | AROVELLA THERAPEUTICS LIMITED: 2025 ESG Report |
Das Unternehmen SYRA HEALTH CORP kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell +0,48 % bei einem Aktienkurs von 0,105 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SYRA HEALTH CORP finden Sie auf Wallstreet Online.